These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 26972925

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Multicentric Castleman's disease in HIV infection: a systematic review of the literature.
    Mylona EE, Baraboutis IG, Lekakis LJ, Georgiou O, Papastamopoulos V, Skoutelis A.
    AIDS Rev; 2008; 10(1):25-35. PubMed ID: 18385778
    [Abstract] [Full Text] [Related]

  • 23. An investigation into the empirical validity of the EQ-5D and SF-6D based on hypothetical preferences in a general population.
    Petrou S, Hockley C.
    Health Econ; 2005 Nov; 14(11):1169-89. PubMed ID: 15942981
    [Abstract] [Full Text] [Related]

  • 24. A comparison of utility measurement using EQ-5D and SF-6D preference-based generic instruments in patients with rheumatoid arthritis.
    Salaffi F, Carotti M, Ciapetti A, Gasparini S, Grassi W.
    Clin Exp Rheumatol; 2011 Nov; 29(4):661-71. PubMed ID: 21813061
    [Abstract] [Full Text] [Related]

  • 25. FDA approval: siltuximab for the treatment of patients with multicentric Castleman disease.
    Deisseroth A, Ko CW, Nie L, Zirkelbach JF, Zhao L, Bullock J, Mehrotra N, Del Valle P, Saber H, Sheth C, Gehrke B, Justice R, Farrell A, Pazdur R.
    Clin Cancer Res; 2015 Mar 01; 21(5):950-4. PubMed ID: 25601959
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Population pharmacokinetics of siltuximab: impact of disease state.
    Nikanjam M, Yang J, Capparelli EV.
    Cancer Chemother Pharmacol; 2019 Nov 01; 84(5):993-1001. PubMed ID: 31482226
    [Abstract] [Full Text] [Related]

  • 30. Siltuximab: first global approval.
    Markham A, Patel T.
    Drugs; 2014 Jul 01; 74(10):1147-52. PubMed ID: 24958337
    [Abstract] [Full Text] [Related]

  • 31. Comparison of the EQ-5D and the SF-6D utility measures in 813 patients with early arthritis: results from the ESPOIR cohort.
    Gaujoux-Viala C, Rat AC, Guillemin F, Flipo RM, Fardellone P, Bourgeois P, Fautrel B.
    J Rheumatol; 2011 Aug 01; 38(8):1576-84. PubMed ID: 21532054
    [Abstract] [Full Text] [Related]

  • 32. Siltuximab for Multicentric Castleman Disease-Letter.
    Teipel R, Ordemann R, Proske U, Dietrich F, Mende M, Ehninger G, Kroschinsky F, Platzbecker U.
    Clin Cancer Res; 2015 Oct 15; 21(20):4740. PubMed ID: 26473194
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Mitoxantrone: a review of its use in multiple sclerosis.
    Scott LJ, Figgitt DP.
    CNS Drugs; 2004 Oct 15; 18(6):379-96. PubMed ID: 15089110
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. [Adalimumab plus methotrexate for the treatment of rheumatoid arthritis: a multi-center randomized, double-blind, placebo-controlled clinical study.].
    Huang F, Zhang FC, Bao CD, Tao Y, Gu JR, Xu JH, Zhu P, Xu HJ, Zhang ZY, Zhao DB, Wu DH.
    Zhonghua Nei Ke Za Zhi; 2009 Nov 15; 48(11):916-21. PubMed ID: 20079321
    [Abstract] [Full Text] [Related]

  • 38. Comparison of EQ-5D and SF-6D utilities in Pompe disease.
    Kanters TA, Redekop WK, Kruijshaar ME, van der Ploeg AT, Rutten-van Mölken MP, Hakkaart L.
    Qual Life Res; 2015 Apr 15; 24(4):837-44. PubMed ID: 25342117
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Siltuximab for multicentric Castleman disease.
    Liu YC, Stone K, van Rhee F.
    Expert Rev Hematol; 2014 Oct 15; 7(5):545-57. PubMed ID: 25110138
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.